1. Home
  2. FATE vs GGR Comparison

FATE vs GGR Comparison

Compare FATE & GGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • GGR
  • Stock Information
  • Founded
  • FATE 2007
  • GGR 2011
  • Country
  • FATE United States
  • GGR Taiwan
  • Employees
  • FATE N/A
  • GGR N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • GGR Auto Manufacturing
  • Sector
  • FATE Health Care
  • GGR Consumer Discretionary
  • Exchange
  • FATE Nasdaq
  • GGR Nasdaq
  • Market Cap
  • FATE 133.0M
  • GGR 114.3M
  • IPO Year
  • FATE 2013
  • GGR N/A
  • Fundamental
  • Price
  • FATE $1.21
  • GGR $0.25
  • Analyst Decision
  • FATE Hold
  • GGR Hold
  • Analyst Count
  • FATE 8
  • GGR 2
  • Target Price
  • FATE $4.14
  • GGR $0.50
  • AVG Volume (30 Days)
  • FATE 1.8M
  • GGR 373.8K
  • Earning Date
  • FATE 05-13-2025
  • GGR 05-08-2025
  • Dividend Yield
  • FATE N/A
  • GGR N/A
  • EPS Growth
  • FATE N/A
  • GGR N/A
  • EPS
  • FATE N/A
  • GGR N/A
  • Revenue
  • FATE $13,335,000.00
  • GGR $304,551,000.00
  • Revenue This Year
  • FATE N/A
  • GGR N/A
  • Revenue Next Year
  • FATE N/A
  • GGR $5.00
  • P/E Ratio
  • FATE N/A
  • GGR N/A
  • Revenue Growth
  • FATE 105.85
  • GGR N/A
  • 52 Week Low
  • FATE $0.66
  • GGR $0.19
  • 52 Week High
  • FATE $5.92
  • GGR $1.76
  • Technical
  • Relative Strength Index (RSI)
  • FATE 53.44
  • GGR 42.46
  • Support Level
  • FATE $1.12
  • GGR $0.24
  • Resistance Level
  • FATE $1.38
  • GGR $0.27
  • Average True Range (ATR)
  • FATE 0.12
  • GGR 0.02
  • MACD
  • FATE 0.01
  • GGR -0.00
  • Stochastic Oscillator
  • FATE 62.22
  • GGR 9.09

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About GGR Gogoro Inc.

Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.

Share on Social Networks: